First study of neoadjuvant use of PARP inhibitor shows promise for early-stage, BRCA breast cancer patients
In a small Phase II study of early-stage breast cancer patients with BRCA1/2 mutations, researchers…
In a small Phase II study of early-stage breast cancer patients with BRCA1/2 mutations, researchers…